Insider Trading Activity Reata Pharmaceuticals Inc (NASDAQ:RETA) – Insider Sold 28,500 shares of Stock

Insider Trading Activity For Reata Pharmaceuticals Inc (NASDAQ:RETA)

Keith Wayne Ward , Insider of Reata Pharmaceuticals Inc (NASDAQ:RETA) reportedly Sold 28,500 shares of the company’s stock at an average price of 36.62 for a total transaction amount of $1,043,670.00 SEC Form

Insider Trading History For Reata Pharmaceuticals Inc (NASDAQ:RETA)

On 6/1/2016 R Kent Mcgaughy Jr, Director, bought 251,553 with an average share price of $12.70 per share and the total transaction amounting to $3,194,723.10.

On 6/1/2016 James Warren Huff, Insider, bought 114,000 with an average share price of $11.00 per share and the total transaction amounting to $1,254,000.00.

On 6/1/2016 A/S Novo, Major Shareholder, bought 750,000 with an average share price of $11.00 per share and the total transaction amounting to $8,250,000.00.

On 6/7/2016 R Kent Mcgaughy Jr, Director, bought 24,220 with an average share price of $17.57 per share and the total transaction amounting to $425,545.40.

On 6/27/2016 Cpmg Inc, Director, bought 73,403 with an average share price of $19.26 per share and the total transaction amounting to $1,413,741.78.

On 6/30/2016 James W Traweek Jr, Major Shareholder, bought 164,600 with an average share price of $19.78 per share and the total transaction amounting to $3,255,788.00.

On 8/16/2016 Colin John Meyer, Insider, bought 7,000 with an average share price of $16.26 per share and the total transaction amounting to $113,820.00.

Analyst Ratings History For Reata Pharmaceuticals Inc (NASDAQ:RETA)

• On 7/24/2017 Piper Jaffray Companies Boost Price Target of rating Buy with a price target of $53.00 ➝ $60.00
• On 7/25/2017 Stifel Nicolaus Reiterated Rating Buy with a price target of $38.00 ➝ $50.00
• On 7/26/2017 LADENBURG THALM/SH SH Reiterated Rating Buy with a price target of $55.00 ➝ $61.00
• On 8/23/2017 Citigroup Reiterated Rating Buy with a price target of $87.00 ➝ $78.00
• On 9/13/2017 Leerink Swann Initiated Coverage of rating Outperform ➝ Outperform with a price target of $43.00
• On 10/6/2017 Jefferies Group Reiterated Rating Buy with a price target of $44.00
• On 10/24/2017 Robert W. Baird Reiterated Rating Buy with a price target of $47.00

Recent Trading Activity for Reata Pharmaceuticals Inc (NASDAQ:RETA)
Shares of Reata Pharmaceuticals Inc closed the previous trading session at 36.05 down -0.61 1.66% with 36.79999923706055 shares trading hands.